In murine arthritis models and human RA synovium, CD8+ TRM cells persist in previously inflamed sites during remission and recruit circulating effector cells via the chemokine (C-C motif) ligand 5 (CCL5) axis, triggering arthritis flare-ups—a phenomenon termed “lesion memory” [20]. Here, CD8A is linked to arthritic joint disease.